Clinical trial to examine the efficacy and safety of brexpiprazole in patients with borderline personality disorder.
Clinical trial to examine the efficacy and safety of an investigational medication compound compared to placebo in patients with Major Depressive Disorder.
Clinical trial to examine the efficacy and safety of brexpriprazole combined with sertraline as treatment for adults with posttraumatic stress disorder.
-
Clinical trial to investigate the efficacy of troriluzole as an adjunctive therapy when added to standard of care to evaluate safety and tolerability of the investigational medication in obsessive compulsive disorder.
-
Clinical trial to examine the efficacy and safety of an investigational medication - esketamine (given as a nasal spray) - in adolescents hospitalized with depression and suicidal ideation.
-
February 23, 2010
The Olin Neuropsychiatry Research Center at the Institute of Living at Hartford Hospital is conducting a study with healthy controls. Qualifying participants will be asked to come in for 1 day to participate in a brain imaging (MRI) and additional testing research project. The study is open to adults aged 18-60.
-
June 24, 2013
Researchers at the Memory Care Center want to learn more about factors that increase risk for developing Alzheimer's disease and related forms of dementia. We are looking for research volunteers who are 45-65 years old and who have had a parent diagnosed with Alzheimer's disease or a related form of dementia.
-
January 04, 2017
This clinical research study is being conducted to evaluate an investigational medication for treatment-resistant depression. We are currently enrolling patients for a clinical research study to look at the effectiveness and dosing requirements of an investigational medication that may help with the symptoms of depression.
-
January 04, 2017
Does your child have depression? If so, s/he may be eligible to participate in a new research study being conducted by Dr. Salma Malik testing the effects of Vilazodone for the treatment of Depression. Participants must be 7 to 17 years of age and generally healthy.
-
January 04, 2017
The Burlingame Research Center at The Institute of Living is conducting a study on patients ages 18-64 that are currently taking an anti-depressant and responding to this therapy. This study will last up to 12 months and financial compensation for time and travel may be provided.